PARTNERING CONTACT "IMPROVING MILLIONS OF LIVES IS IMPORTANT TO ME AS A SCIENTIST" Nurzian Ismail - Principal scientist WORLD'S FIRST GENERIC TO LEADING GNRH ANALOGUE WITH CONTROLLED RELEASE Xbrane is pioneering high demand complex generics. CONTROLLED RELEASE GENERICS LATEST NEWS Xbrane reaches commercial breakthrough with the first batches of Spherotide valued at SEK 7 million Read more >> Xbrane Biopharma AB (publ) releases interim report for the period April - June 2016 Read more >> Xbrane Biopharma AB: Oxford Nanopore Technologies licenses Xbrane Biopharma's protein production technology Read more >> Xbrane Biopharma AB (publ) publishes shareholder letter Read more >> News & Events >> OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY Enabling access to critical medication for life critical diseases BIOSIMILARS EVENTS 07 JUN 2016 Xbrane attending Jefferies Healthcare conference 7-10 June in New York Read more >> 06 JUN 2016 Xbrane attending Bio International 6-9 June in San Francisco Read more >> 25 MAY 2016 Xbrane presenting at "Nasdaq and Aktiespararna investerarkväll” 25 May in Stockholm Read more >> 18 APR 2016 Xbrane attending China Bio 18-19 May in Suzhou Read more >> 10 MAY 2016 Xbrane attending BioEquity 10-11 May in Copenhagen Read more >> 02 MAY 2016 Xbrane presenting at Aktiespararna aktiedag 2 May at Operaterassen in Stockholm Read more >> 04 APR 2016 Xbrane attending BioEurope 4-6 April in Stockholm Read more >> OUR UNIQUE STRENGTHS Addressing increasing global demands An unique platform technology Our vision Our pipeline NEWS NYTEKNIK "DE SÄNKER PRISET PÅ STORSÄLJARNA" PRESS RELEASES XBRANE BIOPHARMA AB : FÖRSTA MILSTOLPEN I KOMMERSIALISERINGEN AV XBRANES RANIBIZUMAB BIOSIMILAR XLUCANE TILLSAMMANS MED PARTNER I IRAN ÄR UPPNÅDD Pressmeddelande &nb (…) PRESS RELEASES XBRANE BIOPHARMA PRESENTERAR VID VATOR SECURITIES UNICORN SUMMIT 2016-02-16 Vator Securities Unicorn Summit är en kapitalmarknadsdag med några av de mest intressanta svenska Life Science-bolagen. Eventet anordnas den 9 mars 2016 på IVA i Stockholm, med start klockan 15:00. Xbrane Biopharma är ett av fem utvalda bolag som ska presentera under eftermiddagen. För (…) Xbrane Biopharma Banvaktsvägen 22 17148 Solna Sweden info@xbrane.com About Xbrane is a biopharmaceutical company specialized in high demand complex generics. The segment have a high entry barrier, driven by high production complexity and the need of specific Know- How. Links Technologies Products Investors News & Events Partnering Social media